Jacobs Levy Equity Management, Inc Incyte Corp Transaction History
Jacobs Levy Equity Management, Inc
- $24.7 Billion
- Q3 2024
A detailed history of Jacobs Levy Equity Management, Inc transactions in Incyte Corp stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 92,782 shares of INCY stock, worth $7.21 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
92,782
Previous 155,495
40.33%
Holding current value
$7.21 Million
Previous $9.43 Million
34.95%
% of portfolio
0.02%
Previous 0.04%
Shares
28 transactions
Others Institutions Holding INCY
# of Institutions
640Shares Held
187MCall Options Held
729KPut Options Held
479K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.39 Billion21.76% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.66 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.4MShares$1.58 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA15.3MShares$1.19 Billion0.61% of portfolio
-
State Street Corp Boston, MA10.6MShares$820 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $17.3B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...